erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Tuberculosis D014376 20 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Otitis Media D010033 12 associated lipids
Adenocarcinoma D000230 166 associated lipids
Bacterial Infections D001424 21 associated lipids
Otitis Externa D010032 8 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Stomach Diseases D013272 7 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Alveolitis, Extrinsic Allergic D000542 6 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
JAY JM Further studies on staphylococci in meats. IV. The bacteriophage pattern and antibiotic sensitivity of isolates from nonfrozen meats. 1962 Appl Microbiol pmid:14451458
DENISENKO VA [Effecicacy of the peroral use of erythromycin in pyoderma]. 1962 Vestn Dermatol Venerol pmid:14026998
DI CARLO R and DE MARINIA E [Pharmacological research on a new water-soluble salt of erythromycin]. 1962 Chemotherapia (Basel) pmid:14027517
DITTLER EL Upper abdominal pain and intrahepatic cholestasis as manifestations of sensitivity to ilosone. 1962 Am. J. Gastroenterol. pmid:14028076
KOYA G et al. [Analysis of 54 cases of septicemia]. 1962 Jpn. J. Infect. Dis. pmid:14035265
REED C and RITCHIE F Toxic jaundice due to propionyl erythromycin ester lauryl sulphate ("Ilosone"). 1962 Med. J. Aust. pmid:14037477
RILEY WA Hepatitis following administration of Ilosome. Case report. 1962 N C Med J pmid:14038696
KATO Y et al. [Studies on propionyl erythromycin lauryl sulfate (PELS)]. 1962 J Antibiot B pmid:14042115
RAVINA A [Burns]. 1962 Annee Ther pmid:13990817
SAKAUE E et al. [Clinical application of "ilotycin" ophthalmic solution]. 1962 Nihon Ganka Kiyo pmid:13990955
SCIOLI C [Clinical and biological study of an antibiotic combination of demethylchlortetracycline and erythromycin laurylsulfate propionate]. 1962 Riforma Med pmid:13992466
TAUBENECK U Susceptibility of Proteus mirabilis and its stable L-forms to erythromycin and other macrolides. 1962 Nature pmid:13993473
VEIS RA and STOROZHEV Ia [On the pharmacology of erythromycin and its derivatives]. 1962 Antibiotiki pmid:13996561
WILLCOX RR Treatment of early venereal syphilis with antibiotics. 1962 Br J Vener Dis pmid:14000784
WILLIAMSON GM and ZINNEMANN K The susceptibility of coliform bacilli to erythromycin. 1962 Antibiot Chemother (Northfield) pmid:14007243
YAMAMOTO C and KISHIMOTO K [Therapeutic results with ilotycin in refractory cases of syphilis]. 1962 Chiryo pmid:14008824
FEAR EC and EDWARDS G Antibiotic regimes in chronic bronchitis. 1962 Br J Dis Chest pmid:13944632
GASNIER P [Propionyl-erythromycin alone and associated with sulfonamides in urology]. 1962 Clinique (Paris) pmid:13946710
GILBERT FI Cholestatic hepatitis caused by esters of erythromycin and oleandomycin. 1962 JAMA pmid:13947810
ISHIGAMI J et al. Studies on the prevention of infection by the addition of various bacteriocidal agents to the urographic media. 1962 Bull Osaka Med Sch pmid:13956825
JIJAKLI-SOMVILLE J [Pemphigus vegetans of the buccal, pharyngeal and laryngeal mucosa]. 1962 Arch Belg Dermatol Syphiligr pmid:13957748
BASS TM [On the problem of the inhibition of the development of resistance to erythromycin in staphylococci]. 1962 Antibiotiki pmid:13969871
POMINI P and TARTAGLIA G [On the therapeutic efficacy of a combination of demethylchlortetracycline with erythromycin laurylsulfate in obstetrics and gynecology]. 1962 Quad Clin Ostet Ginecol pmid:13972087
AFANAS'EV BA [Experience in the use of erythromycin in the treatment of acute gonorrhea in men]. 1962 Vestn Dermatol Venerol pmid:13859516
NINEHAM AW Erythromycin et al. 1962 Lancet pmid:13938729
OKOSHI M [Recent trends in gonorrhea]. 1962 Chiryo pmid:13939834
PALESI S and LAZZARI R [The combination of the laurylsulfate of erythromycin propionate and demethylchlortetracycline in the treatment of various infectious processes in infants]. 1962 Clin Pediatr (Bologna) pmid:13941194
PATTEE PA and BALDWIN JN Transduction of resistance to some macrolide antibiotics in Staphylococcus aureus. 1962 J. Bacteriol. pmid:13941896
DOLEZALOWA M and ZASOWSKI A [Sensitivity of Staphylococcus aureus in vitro to erythromycin, oleandomycin triacetate and novobiocin in suppurative surgical diseases]. 1962 Pol Przegl Chir pmid:13887010
EIDUS L et al. The affinity for monkey tissue of five antibiotics having erythromycin-like spectra. 1962 Chemotherapia (Basel) pmid:13889602
ROBINSON MM Demonstration by "challenge" of hepatic dysfunction associated with propionyl erythromycin ester lauryl sulfate. 1962 Antibiot Chemother (Northfield) pmid:14492925
ROBINSON MM Hepatic dysfunction associated with triacetyloleandomycin and propionyl erythromycin ester lauryl sulfate. 1962 Am. J. Med. Sci. pmid:14492926
GREGL A and MARGGRAF W [Studies on erycinum therapy in surgical diseases. Resistance tests and concentration determinations in different body fluids]. 1962 Munch Med Wochenschr pmid:13901614
GRIFFITH RS and BLACK HR A comparison of blood levels after oral administration of erythromycin and erythromycin estolate. 1962 Antibiot Chemother (Northfield) pmid:13901859
SAEVICH NA [Erythromycin and its use in infants with pneumonia]. 1962 Zdravookhr Beloruss pmid:14495964
GRIFFITH RS and BLACK HR Comparison of antimicrobial activity of erythromycin estolate and demethylchlortetracycline against hemolytic streptococci. 1962 Antibiot Chemother (Northfield) pmid:13901860
GROGAN JB et al. Antibiotic susceptibility of phage type 80/81 strains of staphylococci isolated from hospital and community populations. 1962 Antibiot Chemother (Northfield) pmid:13902091
BOURICHON J [Importance of the suppository form in the administration of propionyl-erythromycin to children]. 1962 Alger Medicale pmid:13871918
TRISHKINA ET [Experimental studies on erythromycin and on its effectiveness in erysipeals]. 1962 Antibiotiki pmid:13922521
KONDRAT'EVA AP and BRUNS BP [Resistance of erythromycin in aqueous solutions]. 1962 Antibiotiki pmid:14458180
LAZAREVA EN et al. [Water-soluble erythromycin salts]. 1962 Antibiotiki pmid:14463086
GOURLAY RH Staphylococcal pneumonia and empyema in infants and children. 1962 Can Med Assoc J pmid:13949603
JUTRAS R [Pleuropulmonary staphylococcal infections in the infant]. 1962 Can Med Assoc J pmid:14452908
KANEDA T et al. Actinomycete antibiotics. III. The biogenesis of erythronolide, the C-21 branched chain lactone in erythromycin. 1962 J. Biol. Chem. pmid:14453579
WEISS E and DRESSLER HR Increased resistance to chloramphenicol in Rickettsia prowazekii with a note on failure to demonstrate genetic interaction among. 1962 J. Bacteriol. pmid:14040210
VIALLIER J et al. [Study of the blood levels obtained with 2 new esters of erythromycin: propionyl erythromycin and propionyl erythromycin lauryl sulfate]. 1961 Nov-Dec Therapie pmid:13925737
HAMMOND JB and GRIFFITH RS Factors affecting the absorption and biliary excretion of erythromycin and two of its derivatives in humans. 1961 May-Jun Clin. Pharmacol. Ther. pmid:13711083
WEIHL C Propionyl erythromycin lauryl sulfate in the treatment of pediatric infections. 1961 Jan-Feb J Obstet Gynaecol Br Emp pmid:13783817
CAGNOLATI G [Antibiotics of the erythromycin group]. 1961 Dec 1-15 Corr Farm pmid:13875528
AZUMA I et al. [Use of propionyl erythromycin lauryl sulfate (S6003)]. 1961 Nihon Ganka Kiyo pmid:13863582